Research
Hormonal
Palmitic acid is essential for physiological functions including maintaining membrane fluidity, protein palmitoylation, and lung surfactant activity (DPPC), and its deficiency can impair lung function.
Palmitic acid is not just 'bad fat'; it is essential for your lungs (surfactant), cell membranes, and protein signaling. Your body makes it and needs it. The problem arises not from its presence, but from excess production due to sugar and calorie overload.
StrongSupportsVERY_HIGH confidence
The tight homeostatic control of PA tissue concentration is likely related to its fundamental physiological role to guarantee membrane physical properties but also to consent protein palmitoylation, palmitoylethanolamide (PEA) biosynthesis, and in the lung an efficient surfactant activity.
Why this rating
The paper details the biochemical necessity of PA in multiple systems (membranes, signaling, lungs) with strong mechanistic explanations.
Source
Palmitic Acid: Physiological Role, Metabolism and Nutritional Implications
Gianfranca Carta et al. · Frontiers in Physiology · 2017
DOI 10.3389/fphys.2017.00902
narrative_reviewCited 789×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Dietary palmitic acid intake does not significantly increase tissue palmitic acid levels because endogenous de novo lipogenesis (DNL) compensates by reducing synthesis, maintaining homeostasis under normal conditions.Good
- Excessive intake of carbohydrates (especially mono and disaccharides) combined with positive energy balance disrupts palmitic acid homeostasis, leading to increased tissue PA, dyslipidemia, and inflammation via Toll-like receptor 4.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →